Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2007-09-25
2010-10-19
Lukton, David (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
Reexamination Certificate
active
07816327
ABSTRACT:
It has now been found that N-L-alpha-aspartyl-L-phenylalanine 1-methyl ester (APM) and/or one of its lower alkyl derivatives can be used to treat allergic contact dermatitis associated with irritating oils such as catechol-containing plant-derived antigens such as poison ivy, poison oak, poison sumac and Asian lacquer tree and oils containing capsaicin. Topical application of APM and/or derivative can reduce or alleviate the symptoms associated with irritation of the skin and/or mucous membranes caused by contact or inhalation of these oils or fumes from burning vegetation containing these oils.
REFERENCES:
patent: 3492131 (1970-01-01), Schlatter
patent: 4259318 (1981-03-01), Duhe et al.
patent: 4547384 (1985-10-01), Kryer
patent: 4594239 (1986-06-01), Pluim, Jr.
patent: 4663151 (1987-05-01), Waali
patent: 4803047 (1989-02-01), Pluim, Jr.
patent: 4861584 (1989-08-01), Powell, Jr. et al.
patent: 5409908 (1995-04-01), Sanchez et al.
patent: 5443847 (1995-08-01), West
patent: 5602183 (1997-02-01), Martin et al.
patent: 5643572 (1997-07-01), Byers et al.
patent: 5654334 (1997-08-01), Edmundson et al.
patent: 5747052 (1998-05-01), Mimikos et al.
patent: 5767109 (1998-06-01), Sanchez et al.
patent: 5998473 (1999-12-01), Edmundson et al.
patent: 6156795 (2000-12-01), Edmundson et al.
patent: 6177467 (2001-01-01), Edmundson et al.
patent: 6326400 (2001-12-01), Edmundson et al.
patent: 6384076 (2002-05-01), Manion et al.
patent: 6436429 (2002-08-01), Peyman
patent: 6630191 (2003-10-01), Amino et al.
patent: 6919374 (2005-07-01), Manion et al.
patent: WO 97/00692 (1997-01-01), None
patent: WO 98/13062 (1998-04-01), None
patent: WO 00/18418 (2000-04-01), None
patent: WO 01/00153 (2001-01-01), None
patent: WO 2004/039348 (2004-05-01), None
patent: WO 2005/094776 (2005-10-01), None
Karlberg Ann-Therese (Chemical Research in Toxicology 21(1), 53-69, 2008).
Szucs, et al.; The Effects of Aspartame on Mast Cells and Basophils, Fd. Chem. Toxic., 1986, pp. 171-174, vol. 24, No. 2, Great Britain.
Marks, et al. 1987 (Oral hyposensitization to poison ivy and poison oak, Arch Dermatol 123:476-478).
Epstein, W.L. 1989, “Topical prevention of poison ivy/oak dermatitis,” Arch Dermatol 125:499-501.
Marks, et al. 1995, “Prevention of poison ovy and poison oak allergic contact dermatitis by quaternium-18 bentonite,” J Am Acad Dermatol 33:212-216.
Gelber, et al. 1997, “Down-regulation of poison ivy/oak-induced contact sensitivity by treatment with a class II MHC binding peptide:hapten conjugate,” J Immunol 158:2425-2434.
Baldwin, et al. 1999 “Regulation of the contact sensitivity response to urushiol with anti-urushiol monoclonial antibody ALG 991,” Arch Dermatol Rews 291:652-658.
Vidmar, D.A. and Iwae, M.K. 1999 “Assessment of the ability of the topical skin protectant (TSP) to protect against contact dermatitis to urushiol (Rhus) antigen,” Am J Contact Dermat 10:190-197.
Stibich, et al. 2000 “Cost-effective post-exposure prevention of poison ivy dermatitis,” Int J Dermatol 39:515-518.
Couteau, et al.; Photodegredation Kinetics Under UV Light of Aspartame, 2000.
Manion, et al; Aspartame Effect in Sickle Cell Anemia, Clinical Pharmacology & Therapeutics, 2001, pp. 346-355, vol. 69. No. 5, United States.
Hansen Eugenia S.
Hemingway & Hansen LLP
Lukton David
Oklahoma Medical Research Foundation
LandOfFree
Inhibition of allergic contact dermatitis by... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Inhibition of allergic contact dermatitis by..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Inhibition of allergic contact dermatitis by... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4157247